Evidence map›Paper›PMID 34274367›Full record

ArticleJournal of hepatology2021

Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury.

Antonio Saviano, Thomas F Baumert

Abstract readEditorialComment
In one paragraph

Article in Journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Liver injury in COVID-19: A minireview.World journal of gastroenterology · 2022
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Antonio SavianoInstitut de Recherche sur les Maladies Virales et Hépatiques (IVH), Inserm U1110, Strasbourg, France; Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; University of Strasbourg, Strasbourg, France. Electronic address: saviano@unistra.fr.
Thomas F BaumertInstitut de Recherche sur les Maladies Virales et Hépatiques (IVH), Inserm U1110, Strasbourg, France; Institut Hospitalo-Universitaire, Pôle Hépato-digestif, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; University of Strasbourg, Strasbourg, France; Institut Universitaire de France (IUF), Paris, France. Electronic address: thomas.baumert@unistra.fr.

Funding

Novel HCV vaccine antigens targeting conserved neutralizing epitopesU19AI123861 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAW, MANSUN · 2016 to 2020
$4.6M
Reverse-engineering precision liver cancer chemopreventionR01CA233794 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HOSHIDA, YUJIN · 2019 to 2023
$3.5M
European Research Council 671231NCI NIH HHS R01 CA233794NIAID NIH HHS U19 AI123861
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Endothelial CellsHepatocytesHumansLiverSARS-CoV-2COVID-19interleukin-6liver injuryLiver sinusoidal endothelial cellsSARS-CoV-2

Identifiers

PMID34274367
PMCPMC8280619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.